Canadian Journal of Gastroenterology and Hepatology / 2018 / Article / Tab 4

Research Article

Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry

Table 4

Patient characteristics and LOS for patients admitted with HN who corrected with initial HN therapy.

Relapse (n = 61)No relapse (n = 49)

[Na+], mmol/L128.0 (4.0)127.0 (5.0)
at time of correction, mmol/132.0 (2.0)132.0 (2.0)
BUN, mg/dL17.0 (17.0)16.0 (16.0)
Cr, mg/dL1.0 (0.5)1.0 (0.9)
BUN:Cr ratio19.1 (9.6)17.4 (11.4)
Tbili, µmol/L4.8 (7.3)4.3 (6.7)
INR, s1.8 (0.8)1.8 (0.5)
Alb, g/doll2.6 (0.9)2.8 (0.7)
MELD score at correction20.9 (6.6)21.9 (11.3)
LOS, 9 (6.0)6 (5.0)
LOS until correction, d3 (2.0)3 (1.0)
LOS after correction, 6 (5.0)2 (3.0)
Death/ hospice, n (%)5 (8)5 (10)

< 0.05.
Values for sodium concentration ([Na+]), [Na+] at time of correction, blood urea nitrogen (BUN), creatinine (Cr), BUN:CR ratio, total bilirubin (Tbili), albumin (Alb), international normalized ratio (INR), Model for End-Stage Liver Disease (MELD) score at correction, length of stay (LOS), LOS until correction, and LOS after correction are median (interquartile range). HN, hyponatremia.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.